Kurnit et al. similarly found higher risk of recurrence of low grade, low stage tumours with CTNNB1 mutations (HR: 5,97; 95 CI [2,69-13,21]; p < 0,001) [32]. The gene discussed is CTNNB1; the disease is neoplasm.